We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Manufacturing Execution System.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Manufacturing Execution System(mes) - List of Manufacturers, Suppliers, Companies and Products

Last Updated: Aggregation Period:Sep 24, 2025~Oct 21, 2025
This ranking is based on the number of page views on our site.

Manufacturing Execution System Product List

31~36 item / All 36 items

Displayed results

Manufacturing Execution System ProManageMES

The manufacturing execution system ProManageMES enables a factory resilient to change through visualization of the manufacturing site!

Three Features of the Manufacturing Execution System ProManage MES [Feature 1: It can be implemented with a small start!] Depending on the factory's situation and budget, the system can be flexibly implemented with only the necessary functions at the right timing. Additionally, with the release of the cloud version of ProManage in February 2021, it has become more affordable to start small. [Feature 2: It is a management-oriented, overall optimization system!] This system is in line with the Industry 4.0 concept, with many successful implementations in Europe, including Germany. Based on international standards (ISA-95 and ISO22400), it allows for smooth data integration between factories and with overseas ERP systems. [Feature 3: It supports the establishment of a resilient manufacturing system!] This system quickly responds to various external changes such as the COVID-19 pandemic and digitalization, while maintaining and strengthening the improvements in QCD that have been pursued in Japanese manufacturing for many years.

  • Other production management systems
  • Injection Molding Machine
  • Production Management System

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Report] MES (Manufacturing Execution System) Market for Life Sciences

"Free samples" are currently being offered! Please check the application method from the [PDF download] button or apply directly through the related links.

According to the latest report from Grand View Research, Inc., the global market size for MES (Manufacturing Execution Systems) for life sciences is expected to record a CAGR of 12.2% from 2024 to 2030, reaching 6 billion USD by 2030. The adoption of MES has emerged as a critical factor in the life sciences industry, helping to enhance efficiency, compliance, and innovation across the entire production process. In North America, the adoption of MES in the life sciences sector is rapidly increasing, highlighting its transformative impact on manufacturing workflows. The life sciences industry, including pharmaceuticals and biotechnology, requires advanced approaches to manufacturing management. MES plays a crucial role by providing integrated, data-driven solutions that meet and exceed regulatory requirements, reduce risks, and ensure product quality.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[42Q Case Study] Major Clean Energy OEM

Flexible MES cloud solution! A case where total costs were reduced and manufacturing speed improved.

We would like to introduce a case study of the cloud-based production management system MES "42Q" implemented at a major clean energy OEM. The company was looking for a new MES solution as a new factory was set to open, requiring the ability to obtain consistent and accurate data from all manufacturing plants, along with the provision of standard batch genealogy and serialization functions. The solution was successfully implemented in less than two months, allowing the new factory to operate as scheduled. Additionally, thanks to the transparency of genealogy and traceability, on-site analysis and product analysis, which previously took three months, could now be executed in just a few days. 【Case Overview】 ■ Challenge: A manufacturing execution system (MES) that provides visibility across multiple manufacturing facilities was needed. ■ Benefits - No need for infrastructure installation or maintenance - Flexibility to handle high-mix and low-mix products with a single solution - Subscription model providing price predictability - Seamless integration between lifecycle management and ERP systems *For more details, please refer to the PDF document or feel free to contact Sanmina.

  • Production Management System

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Report] The Global Market for Manufacturing Execution Systems in Life Sciences

"Free samples" are currently being offered! Please check the application method from the [PDF download] button, or apply directly through the related links.

The market size of manufacturing execution systems in the global life sciences is expected to reach approximately $2.47 billion in 2022, with a projected healthy growth rate of over 12.20% during the forecast period from 2023 to 2030. Manufacturing execution systems (MES) in life sciences refer to software-based solutions designed to manage and control manufacturing processes in the pharmaceutical, biotechnology, and medical device industries. MES facilitates real-time monitoring, tracking, and execution of manufacturing operations, from raw material preparation to final product packaging. Key factors driving the demand for manufacturing execution systems (MES) in life sciences include the rise of biopharmaceuticals, increased technological advancements, and the growing adoption of Pharma 4.0. As the pharmaceutical industry embraces digital transformation and promotes Pharma 4.0, the adoption of MES in the life sciences market is increasing. Initiatives related to Pharma 4.0 aim to enhance connectivity, productivity, compliance, and information management, enabling more effective solutions to industry challenges.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

IT Implementation Subsidy Certification Tool Manufacturing Execution System 'FMES'

Easily input work hours and inspection details using your smartphone or tablet! IT introduction subsidy certified tool.

"FMES" is a manufacturing execution system that manages the understanding and control of manufacturing process conditions, quality data management and analysis, and instructions and support for operators remotely and in real-time. Progress and inspection data entered via smartphones or tablets can be checked in real-time on a management screen through a browser. By utilizing this system, the production process becomes visible, leading to the elimination of dependency on specific individuals. [Features] ■ Supports various business types ■ Various implementation forms available ■ Rich subsystems ■ Easy input *For more details, please download the PDF or feel free to contact us.

  • Process Control System

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] ASEAN Smart Factory Market

The ASEAN smart factory market is rapidly expanding and is expected to reach 28.85 billion USD by 2031.

The ASEAN smart factory market is poised for a transformative decade, with revenues expected to surge from $9.76 billion in 2022 to an estimated $28.85 billion by 2031. This remarkable growth trajectory is supported by a robust compound annual growth rate (CAGR) of 12.80% during the forecast period from 2023 to 2031. The ASEAN smart factory market is anticipated to revolutionize manufacturing processes across various industries, including automotive, electronics, food and beverage, and pharmaceuticals. As more companies recognize the benefits of smart manufacturing, investments in automation and digitalization are expected to rise sharply. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration